Navigation Links
Pregis Announces First Quarter 2008 Financial Results
Date:5/9/2008

3 (147)

Effect of exchange rate

changes on cash

and cash equivalents 2,008 641

Increase in cash and

cash equivalents 7,522 25,769

Cash and cash

equivalents, beginning

of period 34,989 45,667

Cash and cash

equivalents, end of

period $42,511 $71,436

Pregis Holding II Corporation

Supplemental Information

(Unaudited)

Calculation of Adjusted EBITDA ("Consolidated Cash Flow")

Twelve Months Ended March 31,

(dollars in thousands) 2008 2007

Net loss of Pregis Holding II

Corporation $(10,298) $(4,235)

Interest expense, net of interest

income 46,044 43,592

Income tax expense 6,766 8,220

Depreciation and amortization 56,663 53,219

EBITDA 99,175 100,796

Other non-cash charges (income):

Unrealized foreign currency

transaction gains, net (5,061) (6,274)

Non-cash stock based compensation

expense 663 127

Non-cash asset impairment charge 403 -

Impact attributable to application

of purchase accounting - 258

Net unusual or nonrecurring gains or

losses:

Non
'/>"/>

SOURCE Pregis Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Pregis Corporation Appoints New President of Protective Packaging North America
2. Pregis Announces Investor Conference Call to Review 2007 Fourth Quarter and Full Year Financial Results
3. Pregis Announces Fouth Quarter and Full Year 2007 Financial Results
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...kard, from Griffiths School of Nursing and Midwife...the HESTA Australian Nursing Awards. , Professo...patient blood loss during testing procedures, redu...ansfusions among already ill patients. The award w...rnes Crown Entertainment complex. , Nurses rout...
(Date:5/16/2008)...on Public Service Announcement Available, RADNOR,...ition of,National Mental Health Month and Older Pe...n Council (SPC) will offer an important message to...ment. The public service,announcement developed by...o the public health problem of depression and to o...
(Date:5/16/2008)... appointment of Nomura Code Securities Limited as ...r, NEW YORK, May 16 /PRNewswire-FirstCall/ -- Med...ts, Inc. (Amex: MGT ) (the "Company"), and an,ind...Detection (CAD) and,image analysis software which ...sease, today announced the appointment of NM Roths...
(Date:5/16/2008)...16 /PRNewswire/ -- Barbara Senich, B.S.N., M.B.A.,... Services, was honored by,Executive Women of New J...2008 Awards Dinner. The biennial event, held May 1...ized women of professional distinction in New,Jers...of directors at major,New Jersey-based corporation...
Breaking Medicine News(10 mins):Health News:Research talent wins national Innovation in Nursing award 2Health News:Suicide Prevention Group Delivers Much-Needed Message to Pennsylvania's Elderly 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 3Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 3
...ntified how depression plays an important role in ...normal heart beats in a depressed person that can ...or for increased risk of death from heart disease....ington University School of Medicine in St. Louis ...
...led sterols might help to lower your "bad" LDL cho... have been shown to block cholesterol's absorption... minimally absorbed by the intestines. The study ...the cases had high cholesterol, and 14 also had ty...
... of ancient Indian exercise and meditation for the... properties and is popularly used to relieve peopl... trauma and anxiety in patients with breast cance...Bangalore Institute of Oncology on Yoga therapy tr...
...nt found in turmeric or curry powder can prevent t... A new study had found that curcumin, a chemical ...that is required for certain forms of cancer to sp...its a protein called nuclear factor-kappa B (NF-kB...
Other Medicine News:Health News:Yoga Can Be Good For Breast Cancer Patients 2
(Date:5/16/2008)... customer thought leaders -, SAN FRANCISCO, May 1...er and trusted resource for clinical trial managem...estigious academic medical centers, research,insti...roup meeting in San,Francisco. The Velos eResearch...ratively manage thousands of clinical trials., Ov...
(Date:5/16/2008)...onstrating that TYKERB and trastuzumab together re...gression-free survival (PFS), -- Combining TYKERB...side of the HER2 receptor may create a more comple...of TYKERB alone despite patients,previous treatme...rapy, LONDON and PHILADELPHIA, May 16 /PRNewswire...
(Date:5/16/2008)...- Veridex, LLC announced today that,its licensing ...ldings,(LabCorp), has commercially launched a new ... assay uses the biological specificity of ,DNA,met...ation of the gene,GST-Pi. Methylation is a modific...dex is developing the methylation markers in this ...
(Date:5/15/2008)...pulation Most Affected by Disease -, WAYNE, N.J. ...ll/ --,Bayer HealthCare Pharmaceuticals, Inc. and ...announced that Nexavar(R) (sorafenib) tablets,sign...t (HR=0.68;,p-value=0.014) in patients in the Asia...noma (HCC), or primary liver cancer versus those,r...
Breaking Medicine Technology:Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting 2Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Aspirin like compounds increase insulin secretion in otherwise healthy obese people 17896 1Aspirin like compounds increase insulin secretion in otherwise healthy obese people 17896 2Americans Rank Health Care Near the Top of Their Economic Woes New Poll Finds 17893 1Americans Rank Health Care Near the Top of Their Economic Woes New Poll Finds 17893 2Americans Rank Health Care Near the Top of Their Economic Woes New Poll Finds 17893 3Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A 26M Health Science Center 1915 1Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A 26M Health Science Center 1915 2Springer publishes anthology with the Nanoethics Group 4923 1Springer publishes anthology with the Nanoethics Group 4923 2
...(BUSINESS WIRE)--May 23, 2007 - CytoGenix, Inc. (C...cientific Officer will,present an update on precli...Company,s proprietary synDNA(TM) technology at the..., Spain between May 23,and May 25., Dr. Chen comme...NA(TM) based vaccines in mice, rabbits and non-hum...
..., N.J.--(BUSINESS WIRE)--May 23, 2007 - Cytogen,Co...ation of a,review validating the utility of its Pr... the WW domain-containing oxidoreductase,(WWOX), a...vement,in breast, prostate, lung, pancreatic, esop...icle was published in the online,edition (25 April...
Other Medicine Technology:CytoGenix to Present at 2007 International DNA Vaccines Conference,in Spain 2Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 2Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 3Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 4
Hemaseel APR a two-component fibrin sealant vapor heated kit, which is the first commercially available fibrin sealant in the United States. Fibrin sealants are used for two specific reasons: to achi
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical
... designed to allow for three-dimensional correctio...e rods with excellent fatigue resistance to provid... system combines a new dimension in flexibility in...nparalleled durability and ease of use when applyi...
Medicine Products: